Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  China Medical System Holdings Limited    867   KYG211081248

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

(867)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
9.62 9.89 10.38 10.48 10.22 Last
5517000 7401604 9271898 11929730 6256800 Volume
+3.33% +2.81% +4.95% +0.96% -2.48% Change
Financials
Sales 2020 6 573 M 1 014 M 1 014 M
Net income 2020 2 377 M 367 M 367 M
Net cash position 2020 1 529 M 236 M 236 M
P/E ratio 2020 8,96x
Yield 2020 4,15%
Sales 2021 7 253 M 1 119 M 1 119 M
Net income 2021 2 584 M 399 M 399 M
Net cash position 2021 2 739 M 423 M 423 M
P/E ratio 2021 8,28x
Yield 2021 4,44%
Capitalization 21 111 M 3 257 M 3 257 M
EV / Sales 2020 2,98x
EV / Sales 2021 2,53x
Nbr of Employees 4 147
Free-Float 50,8%
More Financials
Company
China Medical System Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture, marketing, promotion and sales of pharmaceutical products. Its main products under direct network include Deanxit, Ursofalk, XinHuoSu, Salofalk, Bioflor and Augentropfen Stulln Mono Eye-drops, among others. Its products under the agency promotion network include ShaDuoLiKa, YiNuoShu and... 
Sector
Pharmaceuticals
Calendar
03/22Earnings Release
More about the company
Notations Surperformance© of China Medical System Holdings Limited
Trading Rating : Investor Rating :
More Ratings
All news about CHINA MEDICAL SYSTEM HOLDINGS LIMITED
01/19CHINA MEDICAL SYSTEM : Shares Jump 7% on Regulatory Nod for Clinical Trial of An..
MT
2020CHINA MEDICAL SYSTEM : 00867.HK) MSCI-ESG Rating Upgraded to AA
AQ
2020CHINA MEDICAL SYSTEM : 00867.HK)'s MSCI-ESG Rating Upgraded to "AA", Reaching th..
AQ
2020COSMO PHARMACEUTICALS N : announces licence of Lumeblue China rights to China Me..
AQ
2020Cosmo Pharmaceuticals Signs License Deal in China for Colonoscopy Lesions Dru..
MT
2020China Medical System Strikes Deal to Distribute UK Pharma's Diagnostic Drug i..
MT
2020CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Related to Sig..
PU
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for interim dividend
FA
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : half-yearly earnings release
2020CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Tildrakizumab ..
PU
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : 2020 Interim Results Announcement
AQ
2020CHINA MEDICAL SYSTEM : Interim results announcement for the six months ended 30 ..
PU
2020CHINA MEDICAL SYSTEM : Terms of Reference of the Remuneration Committee
PU
2020CHINA MEDICAL SYSTEM : Terms of Reference of the Nomination Committee
PU
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for final dividend
FA
More news
News in other languages on CHINA MEDICAL SYSTEM HOLDINGS LIMITED
2020Cosmo cède les droits de licence pour Lumeblue en Chine à CMS
2020Cosmo vergibt China-Lizenz für Methylenblau an China Medical System
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Veröffentlichung des Halbjahresergebnisse..
2020CHINA MEDICAL SYSTEM HOLDINGS LIMITE : publication des résultats semestriels
2020Hong Kong-Lam nommera les juges de la sécurité nationale sur recommandations
More news
Chart CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Duration : Period :
China Medical System Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 10,38 CNY
Last Close Price 8,54 CNY
Spread / Highest target 61,4%
Spread / Average Target 21,4%
Spread / Lowest Target 1,31%
EPS Revisions
Managers and Directors
NameTitle
Kong Lam Chairman, President & Chief Executive Officer
Hong Bing Chen Chief Operating Officer, Executive Director & VP
Yan Ling Chen Chief Financial Officer, Executive Director & VP
Wai Ming Wong Chief Technical Officer
Chi Keung Wu Independent Non-Executive Director